Ludovico Guarini MD Pediatric Hematology Maimonides Medical Center
Read the full transcript »
Speaker: Another misconception, oh, I give a cancer drug are going to give different cancers. Does that happen? Is there a big risk to that? Speaker: There is risk of secondary malignancies in children who have cancer and that risk comes from two areas. One is the fact that kids, who have had cancer, may have genetic abnormalities that may lead them to have a second malignancy later on in life. Again, we are talking about extremely small numbers but there is one possibility, meaning that the child himself may have some biological reason to have that possibility. Speaker: So in other words if we share the data, we do along the treatment, we follow them, we will pick up more information, better marking, better understanding, that we will maybe be more selective how we watch, what we do with, so we get better results. Is that true? Speaker: That is absolutely true. The standard line that I use when I ask a family to participate in one of the studies is that they should think about the fact that the reason why we can offer most children the 80% cure rates that we are talking about for some of the cancer in kids is because thousands of kids before their turn, have gone through the studies and have helped us learn, understand and move forward and get to where we are today. And so, their participation may move those numbers forward.